| Title : Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors - Messer_2000_Pharm.Acta.Helv_74_135 |
| Author(s) : Messer WS, Jr. , Rajeswaran WG , Cao Y , Zhang HJ , el-Assadi AA , Dockery C , Liske J , O'Brien J , Williams FE , Huang XP , Wroblewski ME , Nagy PI , Peseckis SM |
| Ref : Pharm Acta Helv , 74 :135 , 2000 |
| Abstract : Messer_2000_Pharm.Acta.Helv_74_135 |
| ESTHER : Messer_2000_Pharm.Acta.Helv_74_135 |
| PubMedSearch : Messer_2000_Pharm.Acta.Helv_74_135 |
| PubMedID: 10812950 |
Messer WS, Jr., Rajeswaran WG, Cao Y, Zhang HJ, el-Assadi AA, Dockery C, Liske J, O'Brien J, Williams FE, Huang XP, Wroblewski ME, Nagy PI, Peseckis SM (2000)
Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors
Pharm Acta Helv
74 :135
Messer WS, Jr., Rajeswaran WG, Cao Y, Zhang HJ, el-Assadi AA, Dockery C, Liske J, O'Brien J, Williams FE, Huang XP, Wroblewski ME, Nagy PI, Peseckis SM (2000)
Pharm Acta Helv
74 :135